56
UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D .

UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

UNDERSTANDINGOBESITYASADISEASE

CARLOSJORDAN,M.D.

Page 2: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

DisclosuresAppdeveloper:“GuÍa interactiva paraperder peso”

Page 3: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

The patient is a 48 y.o woman with history of type 2 DM sinceage 35. Currently her hemoglobin A1c is 9.6 and she is beingtreated with a combination of metformin, glyburide andpioglitazone; she takes metoprolol for HTN and, last year, shewas started on gabapentin for bilateral neuropathy. She followsa 1800 cal ADA, exercises 1 hour 5x Week, combining Zumbaand other aerobic routines. She is showing progressivehypomenorrhea and her weight, currently 155 lbs, is increasing.She is 5 feet tall, BMI 30.3

Page 4: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Whatwouldyoudonext?

a) startinsulintherapytogetherHba1catgoal.b) discontinueglyburide,gabapentin,pioglitazoneandmetoprolol.

c) referhertoaweightlossspecialist.d) tellhertochangeherdietto1500calandchangeherexerciseprogramto2hoursinsteadof1.

e) referhertoSurgeryforgastricbypass.

Page 5: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Whatisobesity?

Page 6: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Truestatementsaboutobesityincludeallofthefollowing,except:

1.Bodymassindex>30.2.Increaseinbodyfatthatismakingthepersonsick.3.Excessivefatthatcauseshormonal,mechanicalandpsychologicalillness.4.Chronic,inflammatory,relapsingmultifactorialdisease.

Page 7: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Beforethisobesitywasconsideredabehavioraldisorder,wherethepatientwasovereatingan

Missinglastpartofstatement

Page 8: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

ObesityMedicineAssociation

“Obesityisdefinedasachronic,relapsing,multi-factorial,neurobehavioraldisease whereinanincreaseinbodyfatpromotesadiposetissuedysfunctionandabnormalfatmassphysicalforcesresultinginadversemetabolic,biomechanical,andpsychosocialhealthconsequences.”

http://obesitymedicine.org/obesity-algorithm/

Page 9: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Disease

ØIncorrectfunctionoforgan,part,structureorsystemofthebody.ØResultsfromgenetic,developmentalerrors,infection,poisons,nutritionaldeficiencyorimbalance,toxicityorunfavorableenvironmentalfactors.ØManifestsasillness,sickness.

www.dictionary.com

Page 10: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Howisadiposityaccuratelymeasured?

a)Bodymassindex.b)Bioelectricimpedance.c) Underwaterbodyweight.d)DEXAscan.

Page 11: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Indirectmethods

BodyMassIndex•Adolphe Quetelet,1832.•Indirectwaytomeasureadiposity.•Lowcost.•Reproducible.•Nogenderorracialdistinction.

Page 12: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

IndirectMethods

Anthropometricmeasures•Waistcircumference.•Waist/hipratio.•Neckcircumference.•Arereproducible,lowcost,considergenderdifferences.

Page 13: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

IndirectMethods

Bioelectricimpedance• Smallelectriccurrenttravelsthroughbodyandcalculatesamountoffat.• Relativelowcost.• Accuracydependsonlevelofhydration.

Page 14: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

DirectMethods

Dexa,CTorMRIscans

• veryaccurate.• expensive,limits ituse.

Page 15: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Functionsoftheadipocyte are?

A)fatstorage.B)thermogenesis.C)appetiteregulation,glucoseandlipidmetabolism.D)AandB.E)alloftheabove.

Page 16: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Typesofadipocytes

• Whiteadiposetissue(WAT)(visceral)• fatstorage•hormonesecretion

• Brownadiposetissue(BAT)•highinmitochondria• thermogenesis (UCP1-thermogenin)

• BeigePeirce V,CarobbioS,Vidal-Puig A.Nature.2014 Jun 5;510(7503):76-83.doi:10.1038/nature13477.Review.

Page 17: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Whatcausesobesity?

Page 18: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

“Amindislikeaparachute.Itdoesn'tworkunlessitisopen.”

FrankZappa

Page 19: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Theenergybalancetheory

• Lawofconservationofenergy:• Inanclosedsystem,energycannotbecreatedordestroyed.

• Caloriesincaloriesout.

• Doesnotfullyexplainwhyisocaloricdietshavedifferentoutcomes.• Caloriesarenottheonlyvariable.

Obesity and energy balance: isthe tail wagging thedog?WellsJC,Siervo M.Eur JClin Nutr.2011Nov;65(11):1173-89.doi:10.1038/ejcn.2011.132.Epub2011Jul20.Review.

Page 20: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

ComparisonofisocaloricVLCarb,VLFandHUFonbodycompositionandcardiovascular risk

ConclusionIsocaloricVLCARBresultsinsimilarfatlossthandietslowinsaturatedfat,butaremoreeffectiveinimprovingTG,HDL-C,fastingandpostprandialglucoseandinsulinconcentrations.

Noakes M,FosterPR,KeoghJB,JamesAP,Mamo JC,CliftonPM.Comparisonofisocaloricverylowcarbohydrate/highsaturatedfatandhighcarbohydrate/lowsaturatedfatdietsonbodycompositionandcardiovascularrisk.Nutrition&Metabolism.2006;3:7.doi:10.1186/1743-7075-3-7.

Page 21: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Energyexpenditure

•Basicmetabolicrate(BMR)65-70%•Thermic effectoffood(TEF)5-10%•Nonexerciseactivitythermogenesis (NEAT)10-15%•Exercise(E)5-10%

Nonexercise activitythermogenesis--liberatingthelife-force.JInternMed. 2007Sep;262(3):273-87

Page 22: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

HormonalImbalances

• Insulin•Cortisol•TSH•Melatonin•Leptin•GLP-1•Androgens•Estrogen/Progesterone

Page 23: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Insulin

•Masterhormoneoffatstorage.•Stimulateslipogenesis.• Inhibitslipolysis.•Stimulatesproteinsynthesis.•Stimulatesglycogenformation.

Page 24: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Insulin

•Bothcarbohydratesandproteinsstimulatereleaseofinsulin.

•Fathaslessimpactoninsulinrelease.

Page 25: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

InsulinResistance

•Definedclinicallyastheinabilityofaknownquantityofexogenousorendogenousinsulintoincreaseglucoseuptakeandutilizationinanindividualascomparedtoanormalpopulation

Exp Clin Endocrinol Diabetes2001;109(Suppl 2):S135-S148DOI:10.1055/s-2001-18576

Page 26: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Advanceglycation endproducts(AGEs)

•Proteinsorlipidsthatbecomeglycatedasaresultofexposuretosugars.

•HyperglycemiacausesAGEseveninnondiabetics.

•Alsocanbegeneratedbyhightemperaturecooking(enhancesflavor).

•Cancomefromingestedfood.

•TheygenerateROSandinduceinflammation.

•ReceptorforAGE(RAGEs)(PRR)

Proteins/Lipids CHO

AGEs

RAGEs

NFKBInflammation

Vlassara,H.&Striker,G.�E.Nat.Rev.Endocrinol. 7,526–539 (2011);publishedonline24May2011;

Page 27: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Foodcancauseinflammation•Patternrecognitionreceptors(PRRs)

• Tolllikereceptors(TLR).• NODlikereceptor(NLR).• Retinoidacidinduciblegene(RIG)likereceptor.

• CTypeLecithinReceptors(CLRs).• Absenceinmelanoma2likereceptors(ALRs)

•Pathogen-associatedmolecularpatterns(PAMPs)LPS-mannose.

•Damage-associatedmolecularpatterns(DAMPs)Amylin,Glucose,FFAs.

Page 28: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Cortisol

• Stresshormone.• Increasesbloodglucose(gluconeogenesis).

•Promotesinsulinresistance.• Increasesadipocytedifferentiation.

• Increasesvisceralfat.

Selective inhibition of 11 -hydroxysteroiddehydrogenase type 1 as a novel treatment for the metabolic syndromeTomlinson Nature Clinical Practice Endocrinology & Metabolism(2005) 1, 92-99

Page 29: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Circadianrhythmalterations

Decreasedamountofsleepandalteredday/nightcyclesareassociatedwith:

• ElevatedGhrelin(hunger).• Leptin………• IL-6(inflammation).• Foodcravings(especiallyCHO).• Increasedpostprandial glucose.• Insulinresistance.

Taheri S,ShortSleepDurationIsAssociatedwithReducedLeptin,ElevatedGhrelin,andIncreasedBodyMass Index.Froguel P,ed. PLoSMedicine.2004;1(3):e62.

Page 30: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Circadianrhythmalterations• Shiftworkersarepredisposedtometabolicdisordersandcancers.• Circadianregulationofhormones,cortisol andmelatoninbalance.• Bluelightsuppressesmelatoninrelease.

AnthonyHTsang,JournalofMolecularEndocrinology (2014),52,R1–R16

Page 31: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Endocrinedisruptingchemicals(EDCs)

•Exogenouschemicalsubstancesthatmaybindtoendocrinereceptorsandcanstimulate,inhibitorpreventthebindingofthenaturalhormone.

•Alsocalledobesogens.•Mayincreasethenumberorsizeofadipocytes.

•MaylowerBMR.

Page 32: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Endocrinedisruptingchemicals(EDCs)

EDCs Effect

Tobacco Increases IR(50%Obesityinoffspring)

Polycyclic AromaticHydrocarbons (PAHs) Increases visceralfat/Inflammation

Tributyltin (TBT) IncreaseAdipogenesis (PPAR-y)

BisphenolA(BPA) Estrogenic/Dopamine addictivebehavior

FlameRetardants IncreaseAdipogenesisInsulinresistance/ThyroidDysfunction

PolychlorinatedBiphenyls(PCBs) DisruptThyroid Function

Phthalates IncreaseAdipogenesis

Perfluorinated Chemicals(PFCs) IncreasesInsulinandLeptinlevels

Glyphosate Disruption ofGutBacteria(dysbiosis)

Heindel,J. J.et al.Nat.Rev.Endocrinol.11,653–661(2015)

Page 33: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Glyphosate

•Mineralchelation (Cu,Zn,Mn,Mg).

•Toxictosoilmicroorganisms.

•Decreasesbeneficialbacteriainsoil.• Increasesfusariumsp.andpathogenicbacteria,includingsalmonellasp.,C.botulinum,pseudomonassp.

•Decreasesrhizobia,enterococci.

ErratuminJAgric FoodChem.2013Dec26;61

Page 34: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Fructose:the“devil”

• Hasalowglycemic index.

• Canonlybemetabolizedbytheliver.

• CouldleadtofattyliverandNASH.

• Highlyaddictive.

• FFAswillleadtofurtherinsulinresistance.

• Increasesuricacidproduction,increasingBPcontributingtothemetabolicsyndrome.

• ?????????Correctlastpoint.

Metabolicsyndrome;CostasANature502, 181–182 (10October2013)

Page 35: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Fructose:itis“alcoholwithoutthebuzz”

RobertLustig MD,AmericanSocietyforNutrition.Adv.Nutr.4:226–235,2013;

Page 36: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Artificialsweetenersandfoodadditives

• Artificialsweetenersarelikelytocauseweightgain(adiposity).

• Mayincreaseriskoftype2DM,promotinginsulinresistance.

• Effectsarelikelyrelatedtothealterationinthemicrobiota.

• Foodemulsifiersalsodisruptthemicrobiota (soylecithin).

• Monosodiumglutamate(MSG)increasesinsulinsecretion.

Jotham Suez,Nature 514,181–186(09October2014)

Page 37: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Nutritionaldeficiency

•Obesityisachronicinflammatorydisorderthatdepletesthebodyofnutrients,causingmalnutrition.•Thelackofnutrientsfurtherimpairsinsulinsignalingandpredisposestotype2DM.

ViaM.TheMalnutritionofObesity:MicronutrientDeficienciesThatPromoteDiabetes.ISRNEndocrinology.2012;2012:103472. doi:10.5402/2012/103472.

Page 38: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Nutrient Effect

VitaminD B Cellfunction/IR

Chromium Enhancesinsulin signal /IR

Biotin Hexokinase,hepaticuptakeofglucose/IR

Thiamine Glycolysis, TCA/def increaseAGEs

Magnesium EnhancesinsulinSignal/IR

Selenium Insulinmimeticeffect

Zinc Insulinmimeticeffect– Celldivision

ViaM.TheMalnutritionofObesity:MicronutrientDeficienciesThatPromoteDiabetes.ISRNEndocrinology.2012;2012:103472. doi:10.5402/2012/103472.

Page 39: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

MitochondrialDysfunction

•MitochondriasconvertnutrientsintoATP.

•Mitochondriasdeclinewithage.(infunction,numberorboth?)

•Fataccumulationincreaseswithageduetodecreasedfatoxidation.

•GlucoseoxidationincreasesROS.•FatOxidationdecreasesROS.•Propernutritionisrequiredfornormalfunction.

•Firststatementisincorrect.

Page 40: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Howdoyouincreasethenumberofmitochondrias ?

Page 41: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

AMPKupregulation

•Fasting.•Muscularstrengthexercises.•Lowglucosediet.•Hypoxia.•Coldexposure.•Near-infraredlight.

Page 42: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Isobesityiatrogenic?

Page 43: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Thefollowingmedicationsareassociatedwithweightgain,except:a) Insulin.b) Sulfonylureas.c) Betablockers.d) Antihistaminics.e) Exenatide .f) SSRIs.

Page 44: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Medicationsthatcauseorworsenfataccumulation

Drug Possiblemechanism

Insulin Worsensinsulin resistance

Sulfonylureas Increasestherelease ofinsulin

TZDs PPARY,increases Lipogenesis

Betablockers B3R, decreasesBMR10%

SSRIs,Fluoxetine, Paroxetine, Unknown

Steroids Increasesblood sugars

Xenoestregen’s andProgestin's Hormonal disruption

Statins Insulin Resistance

PPIs Alterationonthemicrobiome

THC Increases appetite

HCTZ InsulinResistance

Page 45: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Medicationsthatcauseorworsenfataccumulation

Drug Possiblemechanism

TCAsAmitriptyline, Doxepin,NortriptylineMirtazapine

Unknown

AntipsychoticsLithium,Haloperidol, risperidone,olanzapine

Unknown

H1antagonistsCetirizine, Fexofenadine

Unknown

MAOiSelegiline,Phenelzine

Unknown

AntiepilepticdrugsValproic Acid,Carbamazepine,Gabapentin,

Unknown

Page 46: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Appetiteregulationandweightgain

•Hypothalamic(ARC)controlofappetite.

•Orexigenicpathway(Hunger-POMC).

•Anorexigenicpathway(Satiety-NPY-AgRP).

•Multiplesystemsinvolved:pancreas,gut,brain.

•Systemfeedbackmechanisminhibitedbyfood:• fat(CCK)• carbs (Insulin/Leptin)• proteins(GLP1/PP)

PerryB,WangY.Appetiteregulationandweightcontrol:theroleofguthormones. Nutrition&Diabetes.2012;2(1):e26-.doi:10.1038/nutd.2011.21.

Page 47: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

GeneticsofObesity5%ofobesityisattributabletogeneticdefects

◦ mostcommongeneticabnormalityisadefectonthemelanocortin receptor4(MCR4).

◦ leptin andleptin receptordefects.◦ POMCmutations.◦ Prader-Willysyndrome(hypotonia-hyperphagia).

◦ Bardet–Biedl syndrome(RP-polydactyly)

Youngage,hyperphagiaFarooqi IS (2006) The severely obese patient—a genetic work-up

Nat Clin Pract Endocrino Metabol 2: 172–177 doi:10.1038/ncpendmet0137

Page 48: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

EpigeneticsofObesity

• Inheritableandreversiblephenomenathataffectgeneexpressionwithoutalteringtheunderlyingbasepairsequenceresultingfromenvironmentalinfluence.

• DNAmethylation,histonemodificationandchromatinremodelingareinfluencedbydiet.

• Intrauterinemalnutritionpredisposestoobesityanddiabetesintheoffspring(transgenerational).

Page 49: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Areyourgutbacteriamaking

youfat?

Page 50: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Microbiota andobesity

• 100trillionbacteria.

• >1000species.

• 90%firmicutes andBateriodetes (?????)• Actinobacteria

• Dietaltersthemicrobiome.

• Prebiotics (foodforthemicrobiota)fiber–RS.

• Probiotics (alivemicroorganisms).

• Symbiotics (preandprobiotics).

• Braingutaxis,gut-liveraxis.

Page 51: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Microbiota andObesity•Modulationoftheinflammatoryresponse.

•Fiber➡️ SCFA➡️ GLP-1/Inflammation.•Formationofsecondarybileacids

• lipidmetabolism

•GLP-2I\intestinalpermeability/endotoxemia.

•Endocannabinoid system.•Fasting-inducedadiposefactor(ANGPTL4)• InhibitsLPL(hypertriglyceridemia)

Page 52: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

LeanGutMicrobiota ObeseGut Mibrobiota

NormalratioofFirmicutes/BacteriodetesMoreDiversity

Increased FirmicutesLessDiversity

Normal Satiety(⬆GLP-1-PYY) LessSatiety(⬇GLP-1-PYY)

Decreasedfecal SCFA IncreasedfecalSCFAs(Propionate)

⬆AMPK/ FatOxidationIncreasedFIAF

⬇ AMPK/FatOxidationDecreasedFIAF(Lipogenesis)

⬆ Insulin Sensitivity ⬇ Insulinsensitivity

⬇ Inflammation(LPS) ⬆ Inflammation(LPS)

⬆ ButyricAcid ⬇ ButyricAcid

Front.Endocrinol., 07April2014|http://dx.doi.org/10.3389/fendo.2014.00047

Page 53: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Whatwouldyoudonext?

a) startinsulintherapytogetherHba1catgoal,discontinueglyburide,gabapentin,pioglitazoneandmetoprolol.

b) referhertoaweightlossspecialist.c) tellhertolowerherdietto1500calandmakeherexercise2hoursinsteadof1.

d) referhertoSurgeryforgastricbypass.

Page 54: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

This patient has a chronic inflammatory process that iscausing her to store fat while she is unable to use fat thatshe has already stored. It is also causing her moreinflammation, likely from a disrupted microbiome due topoor dietary choices, lack of sleep, hormonaldysregulation and epigenetic mediated factors.

Changing her medications would likely help her to looseweight.

Page 55: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

TheHorizon…..Thefoodandbeverageindustryspendsapproximately$2billionperyearmarketingtochildren.

Thefastfoodindustryspendsmorethan$5millioneverydaymarketingunhealthyfoodstochildren.

Nearly40%ofchildren’sdietscomefromaddedsugarsandunhealthyfats.

Kidswatchanaverageofovertenfood-relatedadseveryday(nearly4,000/year).

http://www.preventioninstitute.org

Page 56: UNDERSTANDING OBESITY AS A DISEASE€¦ · UNDERSTANDING OBESITY AS A DISEASE CARLOS JORDAN, M.D . Disclosures App developer : “GuÍainteractivapara perderpeso” The patient is

Takehomepoints

• Itisdetrimentalforpatientcaretoassumethatpatientseattoomuchandlackthewillpowertoexercise.

•Wearebarelybeginningtounderstandthecomplexityofthehumanbodyanditsinteractionwiththeatoxicenvironment,includingthemicrobiome.

• Iatrogenicobesityplaysabigroleinthepersistenceofthedisease.

• Getmotivated,learnmoreaboutobesity.